AzTrials
AzTrials

Appetitive BehaviorNCT03154606

The Effects of Protein Source on Appetite Control, Satiety, and Subsequent Food Intake

A study testing Micellar Casein (#1), Micellar Casein (#2) and Calcium Caseinate in people with Appetitive Behavior, run by Purdue University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The investigators propose a randomized, tightly-controlled breakfast trial in normal to overweight adults that will test whether the consumption of various types of protein-rich meals, containing ~24g of protein, will differentially alter food intake and meal initiation through proposed appetite and satiety… Read more about this study

Who is it for?
Ages 20 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Appetitive Behavior
What is being tested?
Micellar Casein (#1), Micellar Casein (#2) and Calcium Caseinate
Could I receive a placebo?
No, everyone receives an active treatment
How many people
35 participants
Where
1 siteUnited States
Study dates
21 Mar 2017to 27 Jul 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Males and females
  • All ethnicities
  • Age: 20-40y
  • BMI/BMI Percentile: 18.5-29.9 kg/m2
  • Consumes breakfast (>110 kcal prior to 10 am) at least 5 days/week for the past year
  • Never smoked or used other tobacco products
Show all 10Show fewer
  • Willing to consume the study breakfasts
  • Generally healthy (as assessed by Medical History Questionnaire)
  • Health conscious as determined by answering yes to 3 pre-screening health \& lifestyle questions
  • Rating of ≥ 5 illustrating a minimum of "neither like nor dislike on a hedonic 9 pt taste test of all testing treatments

Who cannot join

  • Clinically diagnosed with an eating disorder
  • Metabolic, hormonal, and/or neural conditions/diseases that influence metabolism or appetite
  • Currently or previously on a weight loss or other special diet (in the past 6 months)
  • Gained/lost ≥4.5kg over the past 6 months
  • Donated (or plan to donate) blood through the American Red Cross within the past 6 months (or future 6 months)
  • Taking medication that would directly influence appetite (weight-loss drugs or antidepressant, steroid, or thyroid medication, unless dosage has been stable for at least 6 months)
  • Not willing or able to complete all study testing procedures
  • Clinically diagnosed with a sleeping disorder

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Purdue University

    West Lafayette, Indiana, 47907

Other trials in United States

About this study

The investigators propose a randomized, tightly-controlled breakfast trial in normal to overweight adults that will test whether the consumption of various types of protein-rich meals, containing ~24g of protein, will differentially alter food intake and meal initiation through proposed appetite and satiety mechanisms.

Aim 1: To examine whether the consumption of protein-rich meals that vary in protein quality (source) effect:

Read more
  1. postprandial feelings of hunger, fullness, desire to eat, prospective food consumption
  2. postprandial fluctuations in key appetite and satiety hormones
  3. eating initiation (i.e., motivation to eat (again))
  4. food cravings

Aim 2: To examine whether the consumption of protein-rich meals that vary in protein quality (source) effect:

  1. energy intake and food choice within the breakfast meal
  2. energy intake and food choice at the next eating occasion
  3. energy intake and food choice across the entire day
Read the detailed description

Experimental Design: For 3 consecutive days/pattern, the participants will consume the respective treatment, at home, between 7-9 am and refrain from eating or drinking anything other than water until 12:00pm. On day 3, the participants will consume a standardized dinner at home the night before testing. On day 4, the participants will report to the research facility between 6-8 am to complete each 5-h testing day. Upon arrival to the facility, each participant will become familiarized with the testing day procedures. At time -15 min, a baseline set of computerized questionnaires (and/or blood samples) will be completed. At time +0 min, the respective breakfast treatment will be provided. Immediately following the first swallow of the breakfast meal, the participants will be given a questionnaire assessing the palatability. The participants will consume the breakfast within 20 min. After breakfast, the participants will continue to complete the questionnaires (and/or blood samples) every 30 min throughout the 5-h postprandial period. Throughout the day, the participants will also indicate if/when they would like to eat again. Regardless of the participants' meal timing request, at +240min post-breakfast, the participants will be provided with an ad libitum lunch. For the lunch meal, the participants will be given 30 min to "consume as much or as little as possible until comfortably full." Following these procedures, the participants will be allowed to leave the facility. The next day, a dietary recall will be performed to assess daily energy intake across the previous day. Lastly, on day 5 (at home), the participants will be provided with their respective breakfast along with additional carbohydrate and/or fat foods. Once the treatment breakfast is consumed, the participants can select and consume as much of the additional foods as they wish to consume within the breakfast time period (30 minutes).

Being tested
Micellar Casein (#1), Micellar Casein (#2), Calcium Caseinate, Sodium Caseinate, Milk Protein Isolate
Medical subject headings
Appetitive Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Micellar Casein (#1)Other

    The study participants will be provided with breakfast meals to consume. The energy content of the breakfast meals will be standardized to ~250 kcal. The meals will include the same fat content but will contain protein sourced predominantly from micellar casein. All ingredients are GRAS listed and approved.

  • Micellar Casein (#2)Other

    The study participants will be provided with breakfast meals to consume. The energy content of the breakfast meals will be standardized to ~250 kcal. The meals will include the same fat content but will contain protein sourced predominantly from micellar casein. All ingredients are GRAS listed and approved.

  • Calcium CaseinateOther

    The study participants will be provided with breakfast meals to consume. The energy content of the breakfast meals will be standardized to ~250 kcal. The meals will include the same fat content but will contain protein sourced predominantly from calcium casein. All ingredients are GRAS listed and approved.

  • Sodium CaseinateOther

    The study participants will be provided with breakfast meals to consume. The energy content of the breakfast meals will be standardized to ~250 kcal. The meals will include the same fat content but will contain protein sourced predominantly from sodium caseinate. All ingredients are GRAS listed and approved.

  • Milk Protein IsolateOther

    The study participants will be provided with breakfast meals to consume. The energy content of the breakfast meals will be standardized to ~250 kcal. The meals will include the same fat content but will contain protein sourced predominantly from milk protein caseinate. All ingredients are GRAS listed and approved.

  • Pure Protein BlendOther

    The study participants will be provided with breakfast meals to consume. The energy content of the breakfast meals will be standardized to ~250 kcal. The meals will include the same fat content but will contain protein sourced predominantly from pure protein blend. All ingredients are GRAS listed and approved.

  • Whey Protein IsolateOther

    The study participants will be provided with breakfast meals to consume. The energy content of the breakfast meals will be standardized to ~250 kcal. The meals will include the same fat content but will contain protein sourced predominantly from whey protein blend. All ingredients are GRAS listed and approved.

  • Native Whey Protein IsolateOther

    The study participants will be provided with breakfast meals to consume. The energy content of the breakfast meals will be standardized to ~250 kcal. The meals will include the same fat content but will contain protein sourced predominantly from Native Whey Protein Isolate. All ingredients are GRAS listed and approved.

  • Soy ProteinOther

    The study participants will be provided with breakfast meals to consume. The energy content of the breakfast meals will be standardized to ~250 kcal. The meals will include the same fat content but will contain protein sourced predominantly from soy protein. All ingredients are GRAS listed and approved.

  • Pea ProteinOther

    The study participants will be provided with breakfast meals to consume. The energy content of the breakfast meals will be standardized to ~250 kcal. The meals will include the same fat content but will contain protein sourced predominantly from pea protein. All ingredients are GRAS listed and approved.

  • Native Whey: Micellar Casein (50:50) blendOther

    The study participants will be provided with breakfast meals to consume. The energy content of the breakfast meals will be standardized to ~250 kcal. The meals will include the same fat content but will contain protein sourced predominantly from native whey: micellar casein (50:50) blend. All ingredients are GRAS listed and approved.

  • Carbohydrate ControlOther

    The study participants will be provided with breakfast meals to consume. The energy content of the breakfast meals will be standardized to ~250 kcal. The meals will include the same fat content but will contain predominantly carbohydrates as a control. All ingredients are GRAS listed and approved.

Study groups in NCT03154606
Study groupRoleWhat they receive
HP-Beverage BreakfastExperimentalThe study participants will be provided with breakfast meals to consume. The energy content of the breakfast meals will be standardized to ~250 kcal. The meals will include the same fat content but will vary in protein source. All ingredients are GRAS listed and approved. All participants will complete all 12 interventions.
Receives: Other: Micellar Casein (#1); Other: Micellar Casein (#2); Other: Calcium Caseinate; Other: Sodium Caseinate; Other: Milk Protein Isolate; Other: Pure Protein Blend; Other: Whey Protein Isolate; Other: Native Whey Protein Isolate; Other: Soy Protein; Other: Pea Protein; Other: Native Whey: Micellar Casein (50:50) blend
Carbohydrate ControlActive comparatorThe study participants will be provided with breakfast meals to consume. The energy content of the breakfast meals will be standardized to ~250 kcal. The meals will include the same fat content but will primarily as carbohydrates as a control. All ingredients are GRAS listed and approved. All participants will complete all 12 interventions.
Receives: Other: Carbohydrate Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Appetite Sensations of Hunger

    Questionnaires assessing the appetitive sensations of hunger will be completed at specific times throughout each of the the 4-h testing days. The questionnaires contain VAS incorporating a horizontal line rating scale for each response. The questions are worded as "how strong is your feeling of" with anchors of "not all" to "extremely." A summation (area under the curve) will be calculated.

    Measured: 12 testing days across ~6 months

  2. Appetite Sensations of Fullness

    Questionnaires assessing the appetitive sensations of fullness will be completed at specific times throughout each of the 4-h testing days. The questionnaires contain VAS incorporating a horizontal line rating scale for each response. The questions are worded as "how strong is your feeling of" with anchors of "not all" to "extremely." A summation (area under the curve) will be calculated.

    Measured: 12 testing days across ~6 months

  3. Appetite Sensations of Desire to Eat

    Questionnaires assessing the appetitive sensations of desire to eat will be completed at specific times throughout each of the the 4-h testing days. The questionnaires contain VAS incorporating a horizontal line rating scale for each response. The questions are worded as "how strong is your feeling of" with anchors of "not all" to "extremely." A summation (area under the curve) will be calculated.

    Measured: 12 testing days across ~6 months

  4. Appetite Sensations of Prospective Food Consumption

    Questionnaires assessing the appetitive sensations of prospective food consumption will be completed at specific times throughout each of the the 4-h testing days. The questionnaires contain VAS incorporating a horizontal line rating scale for each response. The questions are worded as "how strong is your feeling of" with anchors of "not all" to "extremely." A summation (area under the curve) will be calculated.

    Measured: 12 testing days across ~6 months

Secondary outcomes (14)
  1. Perceived Food Cravings: Sweet

    Questionnaires assessing the food cravings will be completed at specific times throughout each of the 4-h testing days. The questionnaires contain VAS incorporating a horizontal line rating scale for each response. The questions are worded as "how strong is your feeling of" with anchors of "not all" to "extremely." A summation (area under the curve) will be calculated.

    Measured: 12 testing days across ~6 months

  2. Perceived Food Cravings: Salty

    Questionnaires assessing the food cravings will be completed at specific times throughout each of the the 4-h testing days. The questionnaires contain VAS incorporating a horizontal line rating scale for each response. The questions are worded as "how strong is your feeling of" with anchors of "not all" to "extremely." A summation (area under the curve) will be calculated.

    Measured: 12 testing days across ~6 months

  3. Perceived Food Cravings: Savory-fat

    Questionnaires assessing the food cravings will be completed at specific times throughout each of the 4-h testing days. The questionnaires contain VAS incorporating a horizontal line rating scale for each response. The questions are worded as "how strong is your feeling of" with anchors of "not all" to "extremely." A summation (area under the curve) will be calculated.

    Measured: 12 testing days across ~6 months

  4. Perceived Food Cravings: Meat

    Questionnaires assessing the food cravings will be completed at specific times throughout the each of the 4-h testing days. The questionnaires contain VAS incorporating a horizontal line rating scale for each response. The questions are worded as "how strong is your feeling of" with anchors of "not all" to "extremely." A summation (area under the curve) will be calculated.

    Measured: 12 testing days across ~6 months

  5. Perceived Breakfast Palatability

    Questionnaires assessing the breakfast palatability will be completed at specific times throughout each of the 4-h testing days. The questionnaires contain VAS incorporating a horizontal line rating scale for each response. The questions are worded as "how strong is your feeling of" with anchors of "not all" to "extremely." A summation (area under the curve) will be calculated.

    Measured: 12 testing days across ~6 months

  6. Perceived Energy: Sleepiness

    Questionnaires assessing perceived sleepiness will be completed at specific times throughout each of the 4-h testing days. The questionnaires contain VAS incorporating a horizontal line rating scale for each response. The questions are worded as "how strong is your feeling of" with anchors of "not all" to "extremely." A summation (area under the curve) will be calculated.

    Measured: 12 testing days across ~6 months

  7. Perceived Energy: Energy

    Questionnaires assessing perceived energy will be completed at specific times throughout each of the 4-h testing days. The questionnaires contain VAS incorporating a horizontal line rating scale for each response. The questions are worded as "how strong is your feeling of" with anchors of "not all" to "extremely." A summation (area under the curve) will be calculated.

    Measured: 12 testing days across ~6 months

  8. Perceived Energy: Alertness

    Questionnaires assessing perceived alertness will be completed at specific times throughout each of the 4-h testing days. The questionnaires contain VAS incorporating a horizontal line rating scale for each response. The questions are worded as "how strong is your feeling of" with anchors of "not all" to "extremely." A summation (area under the curve) will be calculated.

    Measured: 12 testing days across ~6 months

  9. Food Cravings Inventory

    Participants will fill out a Food Cravings Inventory (FCI) at 4-h post-breakfast on each testing day. The FCI is a reliable and valid self-report measure of general and specific food cravings including cravings for high fat foods, carbohydrates/starches, sweets, and fast food. The FCI defines a craving as an intense desire to consume a particular food (or food type) that is difficult to resist.

    Measured: 12 testing days across ~6 months

  10. Hormonal Response to Interventions: Plasma Ghrelin

    Ten blood samples (4 ml/sample) will be collected throughout each of the the 4-h testing days. The samples will be collected in EDTA test tubes containing pefabloc SC and DPP-IV to reduce protein degradation. Within 10-min of collection, the samples will be centrifuged, and the plasma will be stored at -80°C for future analysis.

    Measured: 12 testing days across ~6 months

  11. Hormonal Response to Interventions: Plasma PYY

    Ten blood samples (4 ml/sample) will be collected throughout each of the 4-h testing days. The samples will be collected in EDTA test tubes containing pefabloc SC and DPP-IV to reduce protein degradation. Within 10-min of collection, the samples will be centrifuged, and the plasma will be stored at -80°C for future analysis.

    Measured: 12 testing days across ~6 months

  12. Hormonal Response to Interventions: Plasma GLP-1

    Ten blood samples (4 ml/sample) will be collected throughout each of the the 4-h testing days. The samples will be collected in EDTA test tubes containing pefabloc SC and DPP-IV to reduce protein degradation. Within 10-min of collection, the samples will be centrifuged, and the plasma will be stored at -80°C for future analysis.

    Measured: 12 testing days across ~6 months

  13. 24-h Energy Intake Dietary Recalls

    To assess the participant's total energy content, macronutrient content, macronutrient consumption, and meal patterning, all subjects will complete a dietary recall following each testing day. The study staff will contact the participant the day after each of the testing days and ask questions related to the quantity, type, brand, preparation, and timing of food consumed following the testing day. Total energy content and macronutrient composition will be calculated using nutrition software.

    Measured: 12 testing days across ~6 months

  14. Ad Libitum Breakfast

    Free-living energy intake at breakfast will be assessed on day 5, of each testing period, through a meal-specific food packout . The participants will first consume the respective breakfast treatment. Additionally, the participants will be provided with an excess of macronutrient-specific foods to consume, ad libitum for the breakfast time period (30 minutes), after the required, respective breakfast treatment. All food items will be initially weighed and recorded. The participants will be instructed to return all uneaten foods as well as all wrappers and containers from consumed food. Any partially eaten, returned items will be weighed accordingly. Breakfast meal energy and macronutrient content will be assessed from these packouts.

    Measured: 12 testing days across ~6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 May 2017
  2. Study start21 Mar 2017
  3. Primary completion27 Jul 2018
  4. Study completion27 Jul 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Crossover
Model description
tightly-controlled, randomized cross-over design
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
35 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03154606
Sponsor's protocol ID
1701018659
Status last verified
Apr 2019
First submitted
19 Apr 2017
Last updated
2 May 2019
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Griffith CA, Leidy HJ, Gwin JA. Indices of Sleep Health Are Associated With Timing and Duration of Eating in Young Adults. J Acad Nutr Diet. 2024 Aug;124(8):1051-1057. doi: 10.1016/j.jand.2024.04.016. Epub 2024 Apr 30.

    PubMed 38697355
  • Braden ML, Gwin JA, Leidy HJ. Protein Source Influences Acute Appetite and Satiety but Not Subsequent Food Intake in Healthy Adults. J Nutr. 2023 Jun;153(6):1825-1833. doi: 10.1016/j.tjnut.2023.04.001. Epub 2023 Apr 6.

    PubMed 37030593
  • Douglas SM, Leidy HJ. Novel Methodological Considerations Regarding the Use of Visual Analog Scale (VAS) Appetite Questionnaires in Tightly Controlled Feeding Trials. Curr Dev Nutr. 2019 May 2;3(6):nzz061. doi: 10.1093/cdn/nzz061. eCollection 2019 Jun.

    PubMed 31206096

Questions about this trial

What is this clinical trial studying?

A study testing Micellar Casein (#1), Micellar Casein (#2) and Calcium Caseinate in people with Appetitive Behavior, run by Purdue University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 May 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Appetite Sensations of Hunger (time frame: 12 testing days across ~6 months). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03154606, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 May 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in